MERS
MERS(中东呼吸综合征)
MERS 相关产品(11)
- GC45580Tizoxanide-d4CAS: 1246817-56-0纯度: >99.00%
An internal standard for the quantification of tizoxanide
- GC47452Imatinib-d3CAS: 1134803-18-1纯度: >99.00%
An internal standard for the quantification of imatinib
- GC47573Lopinavir-d8CAS: 1322625-54-6纯度: >99.00%
An internal standard for the quantification of lopinavir
- GC49165GS-441524 tris-isobutyryl esterCAS: 2563617-99-0纯度: >98.00%
An orally bioavailable prodrug form of GS-443902
- GC49357N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl esterCAS: 1354823-36-1纯度: >98.00%
A synthetic intermediate
- GC61240Remdesivir O-desphosphate acetonide impurityCAS: 1191237-80-5纯度: >99.50%
An intermediate in the synthesis of remdesivir
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC19920 | Ensitrelvir | 2647530-73-0 | >99.00% | |
An inhibitor of SARS-CoV-2 M pro | ||||
| GC39318 | DSHS00884 | 675104-49-1 | >98.00% | |
DSHS00884 是有效的人乳头瘤病毒 E6 抑制剂，IC50 为 10 μM。 | ||||
| GC45580 | Tizoxanide-d4 | 1246817-56-0 | >99.00% | |
An internal standard for the quantification of tizoxanide | ||||
| GC47452 | Imatinib-d3 | 1134803-18-1 | >99.00% | |
An internal standard for the quantification of imatinib | ||||
| GC47573 | Lopinavir-d8 | 1322625-54-6 | >99.00% | |
An internal standard for the quantification of lopinavir | ||||
| GC48036 | Remdesivir-d4 | 2738376-82-2 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC49165 | GS-441524 tris-isobutyryl ester | 2563617-99-0 | >98.00% | |
An orally bioavailable prodrug form of GS-443902 | ||||
| GC49357 | N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl ester | 1354823-36-1 | >98.00% | |
A synthetic intermediate | ||||
| GC50716 | K 22 | 2141978-86-9 | >98.00% | |
An antiviral agent | ||||
| GC61240 | Remdesivir O-desphosphate acetonide impurity | 1191237-80-5 | >99.50% | |
An intermediate in the synthesis of remdesivir | ||||
| GC92121 | P9R (trifluoroacetate salt) | - | >95.00% | |
P9R (trifluoroacetate salt)是一种具有抗病毒活性的肽。 | ||||